Industry Roundup: FDA Investigation Prompts Criminal Charges Against Supplement Marketer

Watson opens supplement ingredient database; FTC shuts down melanoma app marketer; Amway’s Nutrilite wins halal award; more news in brief.

The operator of Floyd Nutrition LLC in Harrisburg, Pa., enters a plea agreement with the Department of Justice following an FDA investigation that determined the firm imported drug-spiked products marketed as weight loss supplements. The U.S. Attorney’s Office of the Middle District of Pennsylvania said on April 15 a criminal information was filed in U.S. District Court in Harrisburg charging Floyd Nutrition owner Cheryl Floyd with introducing misbranded drugs into interstate commerce and money laundering. Floyd Nutrition between July 2010 and July 2014 allegedly marketed weight loss products containing sibutramine, a prescription drug removed from the market in 2010, and phenolphthalein, previously available as an OTC stimulant laxative ingredient until FDA in 1999 reclassified it as not generally safe because it posed a carcinogenic risk, according to DoJ. After FDA detained shipments of the products coming from China intended for Floyd’s business, federal officials in July 2014 seized from Floyd Nutrition products sold online under brands including “Slim Trim U,” “ZXT Slim Bee Pollen” and “Natural Body Solutions.” The plea agreement, which includes forfeiting assets and properties and suggests that Floyd likely will be sentenced to supervised probation, is subject to the approval of the district court. In addition to FDA’s Office of Criminal Investigations, the case was investigated by the Internal Revenue Service Criminal Investigations and the Dauphin County Drug Task Force.

The Nutri-Knowledge database allows consumers as well as manufacturers and marketers to search vitamins, minerals, botanicals and other macro- and micronutrients quickly and easily, says dietary supplement ingredient developer Watson Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

Some Laid Off Employees Called Back At US FDA

 

Some FDA employees who were recently laid off by the Trump Administration are being called back to work, multiple sources confirmed to the Pink Sheet.

US Proposal To Remove Phenylephrine From OTC Monograph Could Stress-Test Streamlined Process

 

Proposed administrative order likely is first to prompt opposition from OTC industry or other stakeholders potentially delaying or deferring the agency’s expectation for moving its proposal to a deemed final order effective one year after it would be published.

FDA Clears Qnovia’s NRT Inhalation IND, Commits To ‘Stimulating’ Smoking Cessation Innovation

 

Qnovia notes NRT inhalation product recently received investigational new drug clearance from FDA as agency and NIH say innovation needed smoking cessation to help improve rate of success for quitting the habit that kills around 500,000 US consumers annually.

Washington State TFCA Violators Likely To Face Conversation Before Penalties – DOE

 

The Washington State Department of Ecology will try to work with companies that violate the Toxic Free Cosmetics Act, rather than reflexively imposing the $5,000-per-violation fine for first-time offenders, says the law’s implementation planner. She noted financial assistance is available for small businesses, as well as incentives for companies adopting measures “beyond compliance.”

More from North America

Washington State TFCA Violators Likely To Face Conversation Before Penalties – DOE

 

The Washington State Department of Ecology will try to work with companies that violate the Toxic Free Cosmetics Act, rather than reflexively imposing the $5,000-per-violation fine for first-time offenders, says the law’s implementation planner. She noted financial assistance is available for small businesses, as well as incentives for companies adopting measures “beyond compliance.”

Adcomm Reform: Getting Needed Information More Important Than Vote Or Discussion

 

US FDA Office of New Drugs Director Peter Stein says review divisions have made the case that a discussion-only meeting would solicit the necessary input.

US FDA’s Petition Procedures No Place For OTC Acetaminophen Pediatric Dosing Enforcement

 

Requests for “enforcement actions are not within the scope of FDA’s citizen petition procedures,” CDER says, rejecting petition dosing device firm Parenteral Technologies submitted as it prepares for workshop on Pediatric Research Equity Act requirements for OTC NDA sponsors.